AMD invests $20M in drug-discovery company Absci, which will move toward greater use of AMD’s GPUs; Absci has 470+ AI chips, most of which are from Nvidia (Belle Lin/Wall Street Journal)

Belle Lin / Wall Street Journal:
AMD invests $20M in drug-discovery company Absci, which will move toward greater use of AMD’s GPUs; Absci has 470+ AI chips, most of which are from Nvidia  —  The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other industries